Cargando…
A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation
Patient: Female, 46-year-old Final Diagnosis: Pure red cell aplasia (PRCA) undergoing ABO-incompatible kidney transplantation Symptoms: End-stage kidney disease (ESKD) with anemia Medication:— Clinical Procedure: — Specialty: Nephrology OBJECTIVE: Rare disease BACKGROUND: Pure red cell aplasia (PRCA...
Autores principales: | Kitpermkiat, Rungthiwa, Thotsiri, Sansanee, Arpornsujaritkun, Nuttaporn, Sangkum, Premsant, Chantrathammachart, Pichika, Kitpoka, Pimpun, Thammanichanond, Duangtawan, Virankabutra, Tanist, Kantachuvesiri, Surasak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302208/ https://www.ncbi.nlm.nih.gov/pubmed/35842751 http://dx.doi.org/10.12659/AJCR.935451 |
Ejemplares similares
-
Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
por: Thammanichanond, Duangtawan, et al.
Publicado: (2022) -
Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients
por: Sutharattanapong, Napun, et al.
Publicado: (2022) -
The Effect of a Booster Dose mRNA Vaccine on COVID-19 Infection in Kidney Transplant Recipients after Inactivated or Viral Vector Vaccine Immunization
por: Thotsiri, Sansanee, et al.
Publicado: (2022) -
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2022) -
Etiologies and Treatment Burden in Adult Patients with Pure Red Cell Aplasia: A Single-Center Experience and Review of Literature
por: Niparuck, Pimjai, et al.
Publicado: (2020)